drugset / Trial / NCT00383383

Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years

NCT00383383

Phase 3 Completed 141 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelPrevention

Summary

Comparison of adjuvanted hepatitis B vaccine to double dose of Engerix™-B in pre- /haemodialysis patients aged ≥15 years.

Timeline

Start
1999-12
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Engerix-B Vaccine
Subject Hepatitis B adjuvanted vaccine Vaccine